Ruboxistaurin Completed Phase 3 Trials for Diabetic Macular Edema (DME) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00133952Effect of Ruboxistaurin on Clinically Significant Macular Edema